Erasca (ERAS.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov13

H.C. Wainwright Analyst Reiterates Buy Rating on Erasca

11:42

Erasca released FY2025 9 Months earnings on November 12 (EST), actual revenue USD 0, actual EPS USD -0.3367

04:00

Erasca released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.1079 (forecast USD -0.1059)

04:00

Nov12

Erasca Inc. Releases Presentation on Oncology Drug Development Pipeline

21:18

Nov6

Laura Prendergast Maintains Buy Rating on Erasca

16:23

Aug13

Erasca released FY2025 Q2 earnings on August 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.12 (forecast USD -0.1146)

03:00

Schedules & Filings

Schedules

Filings

Nov12

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -30.61 M, EPS -0.1079

Aug12

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -33.88 M, EPS -0.1195

May13

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -30.97 M, EPS -0.1093

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change